Delivery Order SPE2DR25D3201-SPE2DR26FT5WM
Award Date 1/28/26
Potential Completion Date 2/19/26
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $12.6K firm fixed-price delivery order to AmerisourceBergen Drug Corp for supply of Inlyta 1 mg tablets (180-count units), with a completion date of January 23, 2026. This non-set-aside contract represents a standard pharmaceutical procurement for federal medical supply needs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of INLYTA 1 mg tablets (180 count) with a ceiling value of $12,565.63. This competitively awarded, non-set-aside contract was executed on November 20, 2025, with an ultimate completion date of December 12, 2025, under firm fixed price terms. The award represents a child delivery order issued against...
- The Defense Logistics Agency awarded a $12,536.26 delivery order to AmerisourceBergen Drug Corp for 60 tablets of INLYTA 5 mg, a pharmaceutical product for medical supply fulfillment. This firm fixed-price delivery order, issued on December 4, 2025, with completion scheduled for December 26, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award utilized competitive procurement procedures with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $12.5K to AmerisourceBergen Drug Corp for INLYTA 5 mg tablets (60-count units) on January 12, 2026, with completion scheduled for February 3, 2026. This is a firm fixed-price, non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 20, 2026, for INLYTA 5 mg tablets (60-count supply) with a ceiling value of $12,536.26. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of February 10, 2026. This award was not set-aside and represents a competitive procurement action. The delivery order is executed...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $12,536.26 firm fixed-price delivery order for INLYTA 5 mg tablets (60-count units) with an ultimate completion date of January 16, 2026. This non-set-aside contract was competitively awarded on December 24, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $11,895.72 delivery order to AmerisourceBergen Drug Corp for INLYTA 5 mg tablets (60-count units) on August 19, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order valued at $11,895.72 by the Defense Logistics Agency on July 22, 2025, for the supply of INLYTA 5 mg tablets in quantities of 60 units. The contract, which carries a firm fixed-price structure with an ultimate completion date of August 12, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $12,536.26 to AmerisourceBergen Drug Corp for 60 tablets of INLYTA 5 mg, a pharmaceutical product used in cancer treatment. This non-set-aside, firm fixed price delivery order was awarded on November 12, 2025, with an ultimate completion date of December 4, 2025. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Inlyta 5 mg tablets (60-count units) valued at $23,791.44. This firm fixed-price delivery order, with an ultimate completion date of August 29, 2025, represents a competitive award with no set-aside designation. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...